Earlier Advanced Health Intelligence Received Deficiency Notification Letter From The Nasdaq Indicating Non-compliance With Minimum Net Shareholders' Equity Requirement Of $2.5M; Does Not Now Affect Its Securities' Listing Or Trading On Nasdaq,
Earlier Advanced Health Intelligence Received Deficiency Notification Letter From The Nasdaq Indicating Non-compliance With Minimum Net Shareholders' Equity Requirement Of $2.5M; Does Not Now Affect Its Securities' Listing Or Trading On Nasdaq,
早些時候，Advanced Health Intelligence收到了納斯達克的缺陷通知信，表明未遵守250萬美元的最低淨股東權益要求；現在不影響其證券在納斯達克的上市或交易，
Advanced Health Intelligence Ltd (NASDAQ:AHI) ("AHI" or "the Company") advises that on November 8, 2023 (Perth time), the Company received a deficiency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC indicating that the Company is not in compliance with the Nasdaq Listing Rule to maintain a minimum of USD$2,500,000 in net shareholders' equity.
Advanced Health Intelligence Ltd（納斯達克股票代碼：AHI）（“AHI” 或 “公司”）表示，2023年11月8日（珀斯時間），公司收到了納斯達克股票市場有限責任公司上市資格人員的虧損通知信，表明該公司未遵守納斯達克上市規則，即維持至少250萬美元的淨股東權益。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。